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INTRODUCTION
Tuberculosis (TB) is the infection caused by Myco-
bacterium tuberculosis complex species that usually 
affects the lungs but can also occur as extrapulmonary 
or disseminated disease. TB in humans, is mainly 
caused by M.tuberculosis, (with a small fraction of 
disease caused by M.bovis and M.africanum)1. This 
report presents the epidemiological data of TB in 
Greece during 2004-2010.
Tuberculosis remains one of the most devastating 
and widespread infections and a major public health 
issue world wide. It is estimated that in 2004 there 
were 8.9 million new cases of TB globally2. One-third 
of the world’s population has been infected with My-
cobacterium tuberculosis and 2 million deaths are at-
tributed to tuberculosis each year3,4.
The WHO Global tuberculosis control report 
shows that the greatest burden of TB is in sub-Saha-
ran Africa and Asia, with TB case notifications in the 
WHO European region constituting less than 10% of 
worldwide notifications.2 In Europe a huge disparity 
in the rates of TB between the western and eastern 
countries exists and it appears to be worsening5. Both 
Ireland and UK had notification rates for all cases of 
<13/100.000 population. On the contrary, in Romania 
and the Russian Federation rates are >100/100.000 
while Kazakhstan reports a rate of 216/100.000. 
TB notifications in Central European countries are 
somewhere in between these two extremes6. Young 
children are the most likely to develop disease after 
infection and are significantly more likely to develop 
extra-pulmonary and severe disseminated disease than 
adults7. Moreover, according to the more recent data 
from ECDC/WHO surveillance report, a decreasing 
trend of mean annual rate between 2005-2010 is no-
ticed. In 2010, 73.996 TB cases were reported by the 
27 EU countries, Iceland and Norway, representing a 
decrease of 7% compared with 2009 and a mean five-
year decline of 4,4% for the period 2006-2010. The 
overall notification rate in 2010 was 14,6 per 100.000 
population and for the first time all EU/EEA countries 
have notification rates below 100 per 100.000 popula-
tion8. 
In June 2005, a new Stop TB Strategy was ap-
proved by the World Health Organization (WHO) 
aiming in drastically reducing the global burden of 
TB by 2015. What this strategy intends to accomplish 
is to cure at least 85% of sputum smear-positive cases 
and to reduce the TB prevalence and mortality by 50% 
compared to the rates in 1990, so that by 2050 it is not 
a public health problem anymore9.
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TB surveillance in Europe is co-ordinated by Eu-
roTB, which is a network of national institutions in 
charge of TB surveillance in the 53 countries of the 
WHO European region. The organization collects in-
formation on TB case surveillance, drug resistance 
and treatment outcomes5. 
In Greece the National Reference Laboratory for 
Mycobacteria (NRLM), sited in Sotiria Chest Disease 
Hospital in Athens, has provided a variety of reference 
services for both the public and the private healthcare 
sector in the field of mycobacterial disease10. Addi-
tionally, the Mandatory Notification System (MNS) 
of the Hellenic Centre for Diseases Control and Pre-
vention (HCDCP) records all necessary data, so as to 
enable the epidemiological recording of the disease 
through data analysis and implement public health 
measures for the TB cases’ immediate environment11. 
The systematic surveillance of the disease is neces-
sary to monitor the indicators set by WHO and Euro-
pean Centre for Disease Control (ECDC), in order to 
control TB on a European and international level. 
According to the recently published report by the 
ECDC and WHO Regional Office for Europe, the case 
notification rate in Greece was 6.0 cases per 100.000 
population in 2008, while only 37,7% of all reported 
TB cases were confirmed by bacterial culture12. Un-
derreporting is an important problem for TB control 
in Greece, where various limitations in the national 
TB monitoring system exist13. Furthermore, migration 
from regions with high TB incidence (Iraq, Afghani-
stan, India, Africa etc.) possibly leads to further un-
derestimation of the TB burden and facilitates further 
spread of the disease. Additionally, a 3-year period 
prospective study, conducted in Central Greece in 
2008, reports that the incidence rate of Mycobacte-
rium tuberculosis complex (MTC) infections of the 
lung was 5.7, 5.28 and 5.1 cases/100.000 in 2004, 
2005 and 2006 respectively14 . 
An analysis of data collected annually through 
the MNS of the HCDCP for the period 2004 - 2010 
shows that in our country an average of 600 cases is 
reported each year. In the country of 11 million people 
is 5,45/100.000. In addition there is a gradual reduc-
tion of notified cases, specifically from 761 in 2004 to 
490 in 2010. The average incidence rate per 100.000 
population by geographic region (NUTS-I, Nomen-
clature of Territorial Units for Statistics) was higher in 
Central Greece and Attica, while the lower incidence 
rate was recorded in the area of the Aegean Islands 
and Crete. With regard to the reported cases in Greeks 
Figure 1. Frequency Distribution of reported cases of tuberculosis by nationality in Greece, 2004-2010 (www.keelpno.gr).
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and the percentage of all reported cases, a decreasing 
trend is observed. On the contrary, the reported cases 
in immigrants are increasing (Figure 1). However, it 
should be noted that studies calculating the number 
of new TB cases through the consumption of anti-TB 
drugs, have shown significant underreporting of the 
disease15. Moreover, the exact rate of TB increase in 
the number of persons with foreign nationality, from 
2004 to 2010 is not actually known. Hence it is rather 
impossible to determine exactly how much of the de-
crease trend of cases between 2004 and 2010 is due to 
underreporting and in what extend the increased trend 
in immigrants is due to a possible recent increase in 
their population15. Overall, during the period 2004-
2010 the 64.1% of the total number of reported cases 
were Greeks, 34% were of foreign nationality, while 
in 1.9% of cases the nationality is not determined15. 
The results of a study, which evaluated the epidemio-
logical and clinical features of childhood TB in the 
Greater Athens area in the last decade, showed that the 
average annual TB incidence was estimated at 5,37 
per 100.000 for children aged <14 years. Time trend 
analysis for the 20-year period revealed a significant 
reduction in the total number of TB cases and in TB 
among children from low-incidence countries16.
Most TB cases in Greeks occurred in persons aged 
65 and older, while most TB cases in foreigners oc-
curred in those aged 25 to 34 years. The difference in 
the age distribution between Greeks and foreigners is 
consistent with the fact that the majority of immigrants 
in our country are people of working age. Regarding 
the type of the disease, the largest proportion (66.4%-
74.9%) of cases was pulmonary, whereas the rate of 
the extra pulmonary locations was low. Additionally, 
cavities were observed on chest x-rays in 20.4% of the 
reported cases in Greeks and in 16.2% of cases occur-
ring in foreign-born persons. The presence of cavities 
is important in the epidemiology of the disease since 
these cases are more contagious15 These data should 
be interpreted with caution, because there are indica-
tions of under-reporting.
Apart from the epidemiology of TB in general it 
is noteworthy that the percentage of cases due to re-
sistant strains is increasing worldwide. According to 
WHO resistance to any of the anti-tuberculosis drugs 
has reached 20% in 2008 globally and was signifi-
cantly higher in Eastern (48.8%) than Western Europe 
(8.9%). Moreover, there appears to be an increase of 
multidrug-resistant TB (MDR-TB) - defined as TB 
resistant to at least isoniazid and rifampin - and of 
extensively drug- resistant TB (XDR-TB) - defined 
as disease caused by MDR strains that are also resis-
tant to at least one fluoroquinolone and one or more 
injectable agents3,4. MDR cases accounted for 5.3% 
in 2008 globally and for 22.6% and 1.5% in Eastern 
and Western Europe respectively. Recently totally 
drug-resistant TB (TDR-Tb) i.e. TB due to strains 
that are resistant to all first- and second-line agents 
has emerged17. In Greece resistance to first-line TB 
drugs remains higher than in most other countries in 
western Europe18. According to a study conducted in 
2010 by the Greek National Reference Laboratory 
for Mycobacteria, RIF resistance was also higher in 
Greece (4%) compared with other western European 
countries, while MDR-TB was much higher in Ka-
zakhstan (14,2%), Estonia (13,3%), Russia (12,5%), 
Latvia (10,8%), Lithuania (9,8%) and Georgia (7,6%) 
than in Greece (4%) and the rest Europe (median Eu-
ropean MDR rate 1,0%)10.
The species of mycobacterium responsible for tu-
berculosis in Greece is mostly M. tuberculosis, while 
M. bovis is following19. It is also very interesting the 
fact that there have been cases in whom disease was 
caused by intravesical instillation of M. bovis-derived 
BCG vaccine strain20, 21. 
In conclusion, tuberculosis is one of the most se-
rious infectious diseases, with incalculable financial 
impact on health systems all over the world. Even 
though, since 2004, the incidence of the disease has 
been reduced globally, the total number of deaths from 
tuberculosis and the percentage of resistant strains 
continue to increase. Additionally, in our country an 
important underreporting of the disease has been ob-
served. Co-operation among all parties involved in the 
diagnosis, treatment, prevention and epidemiological 
surveillance of the disease, through implementation of 
national TB control programs, seems to be the only 
way to control the disease, both in Greece and inter-
nationally.
22 Aristotle University Medical Journal, Vol. 39, Issue 2, June 2012
  1. Forbes BA, SahmDF, Weissfeld AS. Diagnostic Mi-
crobiology 2002. Bailey & Scott’s USA 2002; 48:538-
541.
  2. WHO. Global tuberculosis control-surveillance, plan-
ning and financing. Geneva: World Health Organiza-
tion, 2007, http://www.who.int/tb/publications/glob-
al_report/en/index.html
  3. Spigelman MK. New tuberculosis therapeutics: a 
growing pipeline. J Infect Dis 2007;196:S28-34.
  4. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquino-
lones, tuberculosis, and resistance. Lancet Infect Dis 
2003;3:432-42.
  5. EuroTB. Surveillance of tuberculosis in Europe. Re-
port on tuberculosis cases notified in 2005. http://
www.euroTB.org
  6. Walls T, Shingadia D. The epidemiology of tuberculo-
sis in Europe. Arch Dis Child 2007; 92: 726-9.
  7. Miller F, Seal R, Taylor M. Tuberculosis in children. 
Boston: Little, Brown, 1963. 
  8. h t t p : / / e c d c . e u r o p a . e u / e n / p u b l i c a t i o n s /
Publications/1203-Annual-TB-Report.pdf
  9. Raviglione M, Uplekar M. WHO’s new Stop TB Strat-
egy. Lancet 2006; 367:952-55.
10. Papaventsis D, Nikolaou S, Karabela S, Ioannidis P, 
konstantinidou E, Marinou I, Satini A, Kanavaki S. 
Tuberculosis in Greece: bacteriologically confirmed 
cases and anti-tuberculosis drug resistance, 1995-
2009. Euro Surveill 2010; 15(28): pii=H 
11. http://www.keelpno.gr
12. European Centre for Disease Prevention and Control 
(ECDC)/WHO Regional Office for Europe. Tubercu-
losis surveillance in Europe 2008. Stockholm: ECDC; 
2010. http://www.eurotb.org
13. Jelastopoulou E, Alexopoulos EC, Venieri D, Tsiros G, 
Komninou G, Constantinidis TC, et al. Substantial un-
derreporting of tuberculosis in West Greece-implica-
tions for local and national surveillance. Euro Surveill 
2009; 14(11): pii=19152.
14. Gerogianni I, Papala M, Kostikas K, Petinaki E, Gour-
goulianis KI. Epidemiology and clinical significance 
of mycobacterial respiratory infections in Central 
Greece. Int J Tuberc Lung Dis 2008; 12(7):807-12.
15. http://www2.keelpno.gr/images/stories/keelpno/
newsletter/english/hcdcp_ newsletter _october.pdf.
16. Syridou G, Mavrikou M, Amanatidou V, Spyridis N, 
Prasad P, Papaventsis D, Kanavaki S, Zaoutis T, Tsolia 
MN. Trends in the epidemiology of childhood tuber-
culosis in Greece. Int J Tuberc Lung Dis 2012; Apr 9 
[Epub ahead of print]
17. Velayati AA, Reza Masjedi M, Farnia P, Tabarsi P, 
Ghavani J, ZiaZarifi AH, Hoffner SE. Emergence of 
new forms of totally drug-resistant tuberculosis bacil-
li: super extensively drug-resistant tuberculosis or to-
tally dru-resistant strains in Iran. Chest 2009;136:420-
425.
18. World Health Organization (WHO). Anti-tuberculosis 
drug resistance in the world. Report No 4. The WHO/
IUATLD global project on anti-tuberculosis drug re-
sistance surveillance 2002-2007. Geneva: WHO; 
2008. Available from: http://www.who.int/tb/publica-
tions/2008/drs_report4_26febo8.pdf
19. Neonakis IK, Gitti Z, Petinaki E, Maraki S, Spandidos 
D.A. Evaluation of the GenoType MTBC assay for 
differentianing 120 clinical Mycobacterium Tubercu-
losis complex isolates. Eur J Clin Microbiol Infect Dis 
2007; 26:151-152.
20. Kaklamanos M, Hardavella G Trigidou R, Dionellis 
G, Paissios N, Nikolaos Koulouris, Constantin Gorit-
sas. Multi-organ failure with atypical liver granulomas 
following intravesical Bacillus Calmette-Guerin instil-
lation. World J Hepatol 2011; 3: 79-82.
21. Mavrogenis AR, Sakellariou VI, Tsiodras S, Papagelo-
poulos PJ. Late Mycobacterium bovis spondylitis after 
intravesical BCG therapy. Joint Bone Spine 2009; 76: 
296-300.
ΠΕΡΙΛΗΨΗ: Φυματίωση ονομάζεται η λοίμωξη από είδη του Mycobacterium tuberculosis complex, που κατά κανόνα προ-
σβάλλει τους πνεύμονες, αλλά μπορεί να εμφανιστεί και ως εξωπνευμονική ή γενικευμένη νόσος. Σύμφωνα με τα στοιχεία 
τόσο του ECDC όσο και του WHO, η επίπτωση της νόσου στην Ελλάδα το έτος 2008 ήταν 6,0 νέα κρούσματα ανά 100.000 
πληθυσμού. Η ελλιπής αναφορά νέων κρουσμάτων αποτελεί πρόβλημα για τον έλεγχο της φυματίωσης στην Ελλάδα.
Λέξεις Κλειδιά: Φυματίωση, Επιδημιολογία, Ελλάδα.
Νεότερα επιδημιολογικά δεδομένα της φυματίωσης στον ελλαδικό χώρο.
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